ID   GLT16_MOUSE             Reviewed;         558 AA.
AC   Q9JJ61; Q60GT0;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=Polypeptide N-acetylgalactosaminyltransferase 16;
DE            EC=2.4.1.41;
DE   AltName: Full=Polypeptide GalNAc transferase 16;
DE            Short=GalNAc-T16;
DE   AltName: Full=Polypeptide GalNAc transferase-like protein 1;
DE            Short=GalNAc-T-like protein 1;
DE            Short=pp-GaNTase-like protein 1;
DE   AltName: Full=Polypeptide N-acetylgalactosaminyltransferase-like protein 1;
DE   AltName: Full=Protein-UDP acetylgalactosaminyltransferase-like protein 1;
DE   AltName: Full=UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1;
GN   Name=Galnt16; Synonyms=Galntl1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RA   Osada N., Kusuda J., Tanuma R., Ito A., Hirata M., Sugano S., Hashimoto K.;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Zhang Y., Kwon Y., Kikuchi N., Narimatsu H.;
RT   "Mouse UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
RT   acetylgalactosaminyltransferase, mpp-GalNAc-T16.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=15018805; DOI=10.1016/s1567-133x(01)00019-9;
RA   Nelson P.A., Sutcliffe J.G., Thomas E.A.;
RT   "A new UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase mRNA
RT   exhibits predominant expression in the hypothalamus, thalamus and amygdala
RT   of mouse forebrain.";
RL   Gene Expr. Patterns 1:95-99(2002).
CC   -!- FUNCTION: Catalyzes the initial reaction in O-linked oligosaccharide
CC       biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a
CC       serine or threonine residue on the protein receptor. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-seryl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-O-
CC         [N-acetyl-alpha-D-galactosaminyl]-L-seryl-[protein] + H(+) + UDP;
CC         Xref=Rhea:RHEA:23956, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12788,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:53604,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:67138; EC=2.4.1.41;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-threonyl-[protein] + UDP-N-acetyl-alpha-D-galactosamine = 3-
CC         O-[N-acetyl-alpha-D-galactosaminyl]-L-threonyl-[protein] + H(+) +
CC         UDP; Xref=Rhea:RHEA:52424, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11689, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:67138, ChEBI:CHEBI:87075; EC=2.4.1.41;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250}; Single-
CC       pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: In the CNS, it is predominantly expressed in
CC       several distinct hypothalamic, thalamic and amygdaloid nuclei. The most
CC       abundant level of expression is in the paraventricular, ventromedial
CC       and arcuate nuclei of the hypothalamus, the anterodorsal and
CC       parafascicular nuclei of the thalamus and the central, basomedial and
CC       medial nuclei of the amygdala. Also expressed in cerebral cortex,
CC       lateral septum, habenula and hippocampus.
CC       {ECO:0000269|PubMed:15018805}.
CC   -!- DOMAIN: There are two conserved domains in the glycosyltransferase
CC       region: the N-terminal domain (domain A, also called GT1 motif), which
CC       is probably involved in manganese coordination and substrate binding
CC       and the C-terminal domain (domain B, also called Gal/GalNAc-T motif),
CC       which is probably involved in catalytic reaction and UDP-Gal binding.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The ricin B-type lectin domain binds to GalNAc and contributes
CC       to the glycopeptide specificity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 2 family. GalNAc-T
CC       subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was originally termed Galnt10/pp-GaNTase 10.
CC       {ECO:0000305|PubMed:15018805}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=Putative
CC       polypeptide N-acetylgalactosaminyltransferase-like protein 1;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_mou_524";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB045325; BAA97985.1; -; mRNA.
DR   EMBL; AB175683; BAD52071.1; -; mRNA.
DR   EMBL; AK138883; BAE23810.1; -; mRNA.
DR   EMBL; BC110634; AAI10635.1; -; mRNA.
DR   EMBL; BC125015; AAI25016.1; -; mRNA.
DR   CCDS; CCDS36482.1; -.
DR   RefSeq; NP_001074890.1; NM_001081421.1.
DR   AlphaFoldDB; Q9JJ61; -.
DR   SMR; Q9JJ61; -.
DR   BioGRID; 224406; 1.
DR   STRING; 10090.ENSMUSP00000021558; -.
DR   CAZy; CBM13; Carbohydrate-Binding Module Family 13.
DR   CAZy; GT27; Glycosyltransferase Family 27.
DR   iPTMnet; Q9JJ61; -.
DR   PhosphoSitePlus; Q9JJ61; -.
DR   MaxQB; Q9JJ61; -.
DR   PaxDb; Q9JJ61; -.
DR   PRIDE; Q9JJ61; -.
DR   ProteomicsDB; 263375; -.
DR   Antibodypedia; 25033; 69 antibodies from 17 providers.
DR   Ensembl; ENSMUST00000021558; ENSMUSP00000021558; ENSMUSG00000021130.
DR   Ensembl; ENSMUST00000218943; ENSMUSP00000151619; ENSMUSG00000021130.
DR   Ensembl; ENSMUST00000219993; ENSMUSP00000151829; ENSMUSG00000021130.
DR   GeneID; 108760; -.
DR   KEGG; mmu:108760; -.
DR   UCSC; uc007oaw.1; mouse.
DR   CTD; 57452; -.
DR   MGI; MGI:1917754; Galnt16.
DR   VEuPathDB; HostDB:ENSMUSG00000021130; -.
DR   eggNOG; KOG3738; Eukaryota.
DR   GeneTree; ENSGT00940000158846; -.
DR   HOGENOM; CLU_013477_0_2_1; -.
DR   InParanoid; Q9JJ61; -.
DR   OMA; VCNPREG; -.
DR   OrthoDB; 606683at2759; -.
DR   PhylomeDB; Q9JJ61; -.
DR   TreeFam; TF313267; -.
DR   Reactome; R-MMU-913709; O-linked glycosylation of mucins.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 108760; 2 hits in 73 CRISPR screens.
DR   ChiTaRS; Galnt16; mouse.
DR   PRO; PR:Q9JJ61; -.
DR   Proteomes; UP000000589; Chromosome 12.
DR   RNAct; Q9JJ61; protein.
DR   Bgee; ENSMUSG00000021130; Expressed in ventromedial nucleus of hypothalamus and 166 other tissues.
DR   ExpressionAtlas; Q9JJ61; baseline and differential.
DR   Genevisible; Q9JJ61; MM.
DR   GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004653; F:polypeptide N-acetylgalactosaminyltransferase activity; ISO:MGI.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IBA:GO_Central.
DR   GO; GO:0018242; P:protein O-linked glycosylation via serine; ISO:MGI.
DR   GO; GO:0018243; P:protein O-linked glycosylation via threonine; ISO:MGI.
DR   CDD; cd02510; pp-GalNAc-T; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR045885; GalNAc-T.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   Pfam; PF00652; Ricin_B_lectin; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond; Glycosyltransferase; Golgi apparatus; Lectin; Manganese;
KW   Membrane; Metal-binding; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..558
FT                   /note="Polypeptide N-acetylgalactosaminyltransferase 16"
FT                   /id="PRO_0000059136"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..26
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        27..558
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          428..555
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   REGION          34..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          122..227
FT                   /note="Catalytic subdomain A"
FT   REGION          286..348
FT                   /note="Catalytic subdomain B"
FT   BINDING         163
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         188
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         211
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         212
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         213
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         317
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         345
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250"
FT   BINDING         348
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         351
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         353
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   DISULFID        113..340
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        331..409
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        441..460
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        486..506
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DISULFID        530..543
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   CONFLICT        71
FT                   /note="K -> E (in Ref. 1; BAA97985)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        198
FT                   /note="G -> R (in Ref. 1; BAA97985)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        283
FT                   /note="P -> L (in Ref. 1; BAA97985)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        518
FT                   /note="K -> R (in Ref. 1; BAA97985)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   558 AA;  62875 MW;  1B59DBE8EDDD5C63 CRC64;
     MRKIRANAIA ILTVAWILGT FYYLWQDNRA HAASSSGRGA QRAGGRPEQL REDRTIPLIV
     TGTPSKGFDE KAYLSAKQLK PGEDPYRQHA FNQLESDKLS SDRPIRDTRH YSCPSLSYSS
     DLPATSVIIT FHNEARSTLL RTVKSVLNRT PASLIQEIIL VDDFSSDPED CLLLTRIPKV
     KCLRNDKREG LIRSRVRGAD VAGATVLTFL DSHCEVNVEW LQPMLQRVME DHTRVVSPII
     DVISLDNFAY LAASADLRGG FDWSLHFKWE QIPLEQKMTR TDPTKPIRTP VIAGGIFVID
     KSWFNHLGKY DAQMDIWGGE NFELSFRVWM CGGSLEIVPC SRVGHVFRKR HPYNFPEGNA
     LTYIRNTKRT AEVWMDEYKQ YYYEARPSAI GKAFGSVATR IEQRKKMDCK SFRWYLENVY
     PELTVPVKEV LPGVIKQGVN CLESQGQNTA GDLLLGMGIC RGSAKSPPPA QAWLFSDHLI
     QQQGKCLAAT STLMSSPGSP VILQTCNPKE GKQKWRRKGS FIQHSVSGLC LETKPAQLVT
     SKCQTDAQAQ QWQLLPHT
//
